Ikarian Capital »

Biosante Pharmaceuticals shares owned by Ikarian Capital

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.5M 83k 78.94

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
Citadel Advisors
Global Alpha Capital Management
Dimensional Fund Advisors
Soleus Capital Management
Tang Capital Management
Deep Track Capital
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Nuveen
Ranger Investment Management

View all funds holding Biosante Pharmaceuticals